140 related articles for article (PubMed ID: 8378093)
1. Structural alterations of the NF-kappa B transcription factor lyt-10 in lymphoid malignancies.
Fracchiolla NS; Lombardi L; Salina M; Migliazza A; Baldini L; Berti E; Cro L; Polli E; Maiolo AT; Neri A
Oncogene; 1993 Oct; 8(10):2839-45. PubMed ID: 8378093
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneous chromosomal aberrations generate 3' truncations of the NFKB2/lyt-10 gene in lymphoid malignancies.
Migliazza A; Lombardi L; Rocchi M; Trecca D; Chang CC; Antonacci R; Fracchiolla NS; Ciana P; Maiolo AT; Neri A
Blood; 1994 Dec; 84(11):3850-60. PubMed ID: 7949142
[TBL] [Abstract][Full Text] [Related]
3. The complete exon-intron structure of the 156-kb human gene NFKB1, which encodes the p105 and p50 proteins of transcription factors NF-kappa B and I kappa B-gamma: implications for NF-kappa B-mediated signal transduction.
Héron E; Deloukas P; van Loon AP
Genomics; 1995 Dec; 30(3):493-505. PubMed ID: 8825636
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of expression and role in transcriptional control of the proto-oncogene NFKB-2/LYT-10.
Chang CC; Zhang J; Lombardi L; Neri A; Dalla-Favera R
Oncogene; 1994 Mar; 9(3):923-33. PubMed ID: 8108136
[TBL] [Abstract][Full Text] [Related]
5. Genomic structure of the candidate proto-oncogene BCL3.
McKeithan TW; Ohno H; Dickstein J; Hume E
Genomics; 1994 Nov; 24(1):120-6. PubMed ID: 7896265
[TBL] [Abstract][Full Text] [Related]
6. B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-kappa B p50.
Neri A; Chang CC; Lombardi L; Salina M; Corradini P; Maiolo AT; Chaganti RS; Dalla-Favera R
Cell; 1991 Dec; 67(6):1075-87. PubMed ID: 1760839
[TBL] [Abstract][Full Text] [Related]
7. Rearranged NFKB2 gene in the HUT78 T-lymphoma cell line codes for a constitutively nuclear factor lacking transcriptional repressor functions.
Zhang J; Chang CC; Lombardi L; Dalla-Favera R
Oncogene; 1994 Jul; 9(7):1931-7. PubMed ID: 8208540
[TBL] [Abstract][Full Text] [Related]
8. The involvement of the candidate proto-oncogene NFKB2/lyt-10 in lymphoid malignancies.
Neri A; Fracchiolla NS; Migliazza A; Trecca D; Lombardi L
Leuk Lymphoma; 1996 Sep; 23(1-2):43-8. PubMed ID: 9021684
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional regulatory effects of lymphoma-associated NFKB2/lyt10 protooncogenes.
Kim KE; Gu C; Thakur S; Vieira E; Lin JC; Rabson AB
Oncogene; 2000 Mar; 19(10):1334-45. PubMed ID: 10713675
[TBL] [Abstract][Full Text] [Related]
10. Constitutive expression of lymphoma-associated NFKB-2/Lyt-10 proteins is tumorigenic in murine fibroblasts.
Ciana P; Neri A; Cappellini C; Cavallo F; Pomati M; Chang CC; Maiolo AT; Lombardi L
Oncogene; 1997 Apr; 14(15):1805-10. PubMed ID: 9150386
[TBL] [Abstract][Full Text] [Related]
11. Molecular features of a new human lymphoma cell line carrying both BCL2 and BCL6 gene rearrangements.
Yonetani N; Akasaka T; Akasaka H; Ohno H; Okuma M; Miura I; Takahashi N; Miyanishi S; Okumura A; Muramatsu M; Fukuhara S
Oncogene; 1998 Aug; 17(8):971-9. PubMed ID: 9747876
[TBL] [Abstract][Full Text] [Related]
12. Gene rearrangement and overexpression of PRAD1 in lymphoid malignancy with t(11;14)(q13;q32) translocation.
Seto M; Yamamoto K; Iida S; Akao Y; Utsumi KR; Kubonishi I; Miyoshi I; Ohtsuki T; Yawata Y; Namba M
Oncogene; 1992 Jul; 7(7):1401-6. PubMed ID: 1535701
[TBL] [Abstract][Full Text] [Related]
13. Identification of a novel gene, PSD, adjacent to NFKB2/lyt-10, which contains Sec7 and pleckstrin-homology domains.
Perletti L; Talarico D; Trecca D; Ronchetti D; Fracchiolla NS; Maiolo AT; Neri A
Genomics; 1997 Dec; 46(2):251-9. PubMed ID: 9417912
[TBL] [Abstract][Full Text] [Related]
14. Chromosomal localization of genes encoding the transcription factors, c-rel, NF-kappa Bp50, NF-kappa Bp65, and lyt-10 by fluorescence in situ hybridization.
Mathew S; Murty VV; Dalla-Favera R; Chaganti RS
Oncogene; 1993 Jan; 8(1):191-3. PubMed ID: 8423996
[TBL] [Abstract][Full Text] [Related]
15. Rearrangement and altered expression of the NFKB-2 gene in human cutaneous T-lymphoma cells.
Thakur S; Lin HC; Tseng WT; Kumar S; Bravo R; Foss F; Gélinas C; Rabson AB
Oncogene; 1994 Aug; 9(8):2335-44. PubMed ID: 8036016
[TBL] [Abstract][Full Text] [Related]
16. bcl-1, bcl-2, p53, c-myc, and lyt-10 analysis in cutaneous lymphomas.
Garatti SA; Roscetti E; Trecca D; Fracchiolla NS; Neri A; Berti E
Recent Results Cancer Res; 1995; 139():249-61. PubMed ID: 7597296
[TBL] [Abstract][Full Text] [Related]
17. The gene for interleukin-21 receptor is the partner of BCL6 in t(3;16)(q27;p11), which is recurrently observed in diffuse large B-cell lymphoma.
Ueda C; Akasaka T; Kurata M; Maesako Y; Nishikori M; Ichinohasama R; Imada K; Uchiyama T; Ohno H
Oncogene; 2002 Jan; 21(3):368-76. PubMed ID: 11821949
[TBL] [Abstract][Full Text] [Related]
18. The mouse DNA binding protein Rc for the kappa B motif of transcription and for the V(D)J recombination signal sequences contains composite DNA-protein interaction domains and belongs to a new family of large transcriptional proteins.
Wu LC; Liu Y; Strandtmann J; Mak CH; Lee B; Li Z; Yu CY
Genomics; 1996 Aug; 35(3):415-24. PubMed ID: 8812474
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of primary mediastinal B cell lymphoma.
Tsang P; Cesarman E; Chadburn A; Liu YF; Knowles DM
Am J Pathol; 1996 Jun; 148(6):2017-25. PubMed ID: 8669486
[TBL] [Abstract][Full Text] [Related]
20. The recurrent translocation t(14;20)(q32;q12) in multiple myeloma results in aberrant expression of MAFB: a molecular and genetic analysis of the chromosomal breakpoint.
Boersma-Vreugdenhil GR; Kuipers J; Van Stralen E; Peeters T; Michaux L; Hagemeijer A; Pearson PL; Clevers HC; Bast BJ
Br J Haematol; 2004 Aug; 126(3):355-63. PubMed ID: 15257707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
